Swiss Strategy A.G., Prepares To Launch NicStic, Switzerland's First Healthy Cigarette

Bülach, Switzerland -- Swiss Strategy Aktiengesellschaft has developed a tobacco-free and nicotine-free alternative to traditional tobacco cigarettes to be marketed under the "NicStic" brand name. NicStic all-natural menthol cigarettes are flavored with naturally-occurring marrubiin, a labdane diterpene of "White Horehound" (Marrubium vulgare) as well as a complex mixture of phenolic compounds which contributes to a user experience emulating that of a traditional cigarette. Marrubium vulgare L.: A Phytochemical and Pharmacological Overview.

According to numerous studies on White Horehound (Marrubium vulgare) say when smoked it acts as a potent insecticidal agent, and due to this, it could potentially be useful as a natural insect repellent against malaria infected mosquitoes. White Horehound is a Smokable Herb and has been used for centuries as a substitute for tobacco and is the predominant herbal ingredient in Ricola cough drops. In addition it can be used for supportive benefits or to help cigarette smoker;s quit tobacco. NicStic has been shown to impart numerous benefits to tobacco users who wish to quit, including the alleviation of tobacco withdrawals and the overall reduction of tobacco dependency. Soon after tobacco was introduced into Europe from the New World, it came to be regarded as a remarkable medicinal plant according to Juan R. Sanchez-Ramosa, in The National Center for Biotechnology Information scientific publication: The rise and fall of tobacco as a botanical medicine.

Swiss Strategy A.G. anticipates that NicStic herbal cigarettes will officially be launched in fall 2022. With worldwide tobacco-related deaths now topping eight million fatalities per year, it is clear that the time has come to introduce attractive alternatives to traditional cigarettes to encourage and facilitate positive long-term change for tobacco users. Since 1 May 2010, smoking has been forbidden in Switzerland in enclosed areas when they are open to the public or serve as a workplace for more than one person. Hence it is forbidden to smoke in restaurants, public buildings and offices. Smoking is also forbidden on public transport.

For more info, please visit https://swissstrategy.webnode.co.uk

† These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

SOURCE Swiss Strategy A.G.

Investor Relations:

Marina Krueger, Ph.D.
Chief Medical Officer
Swiss Strategy Aktiengesellschaft
Schützenmattstrasse 71
CH-8180 Bülach, Switzerland
Tel.: +41 79 123 57-84
Email: marinakrueger@vitrx.eml.monster
Blog: https://swissstrategy.blogspot.com
Logo - https://flic.kr/p/2nDZ5pC

About Swiss Strategy A.G.

Swiss Strategy A.G. is a Swiss marketing firm. Its role is to promote science-based innovations in the public interest for the economy and society in Switzerland. Swiss Strategy A.G. promotes limited partnerships between motivated scientists and the Swiss marketplace with inspiring patented inventions for successful Swiss start-ups as well as innovative products and services.

This release was published on openPR.